FHU NOR-SUD
Transcript of FHU NOR-SUD
![Page 1: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/1.jpg)
Dr Florence Vorspan
Dr Elisabeth Avril, Pr Philip Gorwood
FHUNOR-SUD
![Page 2: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/2.jpg)
Substance Use Disorders: A Major Health Issue
• The first avoidable cause of mortality
• Deaths from tobacco, alcohol and illicit drugs increased by 11.3%; 11% and 27.6% in the past 10 years (Stanaway JD, et al. The Lancet 2018)
• Standardized mortality ratio : 4 to 14 for cocaine and opiates (Degenhardt L, et al. Drug Alcohol Depend 2011; Degenhardt L, et al. Addiction 2011)
• A high burden in morbidity and incapacity (Whiteford HA, et al. The Lancet 2013)
• A specific societal demand to face open drug scenes in the North East region of Paris (“Plan Crack” MILDECA, regional health authority ARS, Paris major)
• A specific gap in treatment access (Blanco C, et al. Drug Alcohol Depend 2015)
![Page 3: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/3.jpg)
5 Identified Research Priorities : 3 + 2
• crack-cocaine dependence
• patients with psychiatric conditions and substance use disorders (dual disorders)
• patients with substance use disorder and associated medical conditions
• conduct clinical proof of concept collaborative trials using the FHU starter grant
• translate cutting edge technologies derived from fundamental sciences to the bedside
![Page 4: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/4.jpg)
5 Identified Research Priorities
• crack-cocaine dependence
• patients with psychiatric conditions and substance use disorders (dual disorders)
• patients with substance use disorder and associated medical conditions
• conduct clinical proof of concept collaborative trials using the FHU starter grant
• translate cutting edge technologies derived from fundamental sciences to the bedside
![Page 5: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/5.jpg)
120
4 000
![Page 6: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/6.jpg)
160
6 000
![Page 7: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/7.jpg)
160
10 000
![Page 8: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/8.jpg)
![Page 9: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/9.jpg)
![Page 10: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/10.jpg)
Innovative and structuring nature of the FHU
• combining care and fundamental neuroscience, pharmacology and social sciences teams in collaborative projects
• creating a forum to meet and enrich the bedside from the bench and the reverse
• overcoming the small size of each team alone
• training and technical assistance for those unfamiliar to clinical research
![Page 11: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/11.jpg)
To summarize
• SUD are a major health issue and societal demand
• Structuring partnership
• Scaling up tried-and-proved collaborations
• Reshaping the landscape of SUD research in the next 5 years
![Page 12: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/12.jpg)
Thank You
![Page 13: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/13.jpg)
![Page 14: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/14.jpg)
Back up slides
![Page 15: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/15.jpg)
Deliverables
• Get funding
• Conduct clinical trials
• Publish
• Transfer
![Page 16: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/16.jpg)
FHU Leader Florence Vorspan
FHU Council
composed of the leader + 8 elected representatives
2 representatives of the APHP services
involved
6 services
2 representatives of the GHU services
involved
3 services
2 representatives of the EMS (NGO)
involved
4 NGO
2 representatives of the research units
involved
8 research units
![Page 17: FHU NOR-SUD](https://reader034.fdocuments.in/reader034/viewer/2022051412/627e00525f9250074e44372f/html5/thumbnails/17.jpg)
SWOT of the FHU NOR-SUD
• STRENGHTS• patient access• excellent track record in funding• excellent research units• past successful experience in
including
• OPPORTUNITIES• societal demand « crack plan »• dedicated research funding
• WEAKNESSES• numerous small groups• various cultural backgrounds• thematic fragmentation
• THREATS• high pressure on care detrimental
to research• hospital budget cuts with high
impact on small teams